Press & Media

This is where you will find links to opinion editorials, videos, articles and other media coverage related to Michael Becker:


2018

August 23, 2018 – HPV cancers are increasing, while preventive vaccine is underused, CDC data find– Almost all HPV-related cancers are increasing in the United States, yet the vaccine with the potential to nearly wipe out these malignancies in future generations remains underused. Click here to read the article by Marie McCullough of The Philadelphia Inquirer.

June 6, 2018 – A Biotech Executive Faces End-Stage Cancer As A Patient – Click here to read the article and/or view the video by Matthew Herper of Forbes.

May 24, 2018 – Yardley man has terminal illness, but can’t support GOP ‘right to try’– As he holds his own against terminal neck cancer, Michael Becker can relate to those who want to make experimental drugs more available to people with fatal illnesses. Click here to read the article by Marie McCullough of The Philadelphia Inquirer.

May 24, 2018 – Right To Try Act Poses Big Challenge For FDA – Click here to read the opinion editorial by Michael Becker for Shots!, health news from NPR.

May 22, 2018 – ‘Right to try’ legislation heads to the White House – The House on Tuesday passed “right to try” legislation that would allow people with life-threatening illnesses to bypass the Food and Drug Administration to obtain experimental medications, ending a drawn-out battle over access to unapproved therapies. Click here to read the article by Laurie McGinley for The Washington Post.

May 10, 2018 – HPV-Related Cancers Like Mine Are Avoidable, So Why Aren’t More Kids Being Vaccinated? – Cancer has turned me into an advocate for others.  Click here to read the article by Michael Becker as told to Jo Cavallo in The ASCO Post.

March 22, 2018 – House right-to-try experimental drugs bill succeeds on 2nd attempt Click here to read the article by Donna Young of S&P Global Market Intelligence.

March 14, 2018 – Support Builds, But ‘Right To Try’ Legislation Doesn’t Clear House – The measure lets terminally ill patients apply to try drugs that haven’t yet been approved for treatments. Click here to listen to a replay of the radio segment with host Joshua Johnson for 1A, which is produced by WAMU 88.5, and distributed by NPR.

March 6, 2018 – HPV is causing an oral cancer epidemic in men by outwitting natural defensesMichael Becker of Yardley has stepped up as the face of this immunological inequity. The 49-year-old former biotech executive is health-conscious, clean-living, happily married for 26 years – and battling terminal oropharyngeal cancer, the medical term for malignancies in parts of the mouth and throat. Click here to read the article by Marie McCullough of The Philadelphia Inquirer.

February 24, 2018 – One Man’s Fight to Prevent HPV Infections – Public health experts are sounding the alarm about a rise in head and neck cancers in men caused by the human papillomavirus, commonly referred to as HPV. For one man in particular, getting the word out has become a personal crusade. Click here to view a replay of the TV segment or click here for both the text and video by Dr. Jon LaPook of CBS This Morning Saturday.

February 21, 2018 – Trump pushing ahead on Koch-backed experimental drugs ‘Right to Try’ agenda – Congress is trying to pass a bill that would allow patients with life-threatening diseases to bypass the FDA in receiving experimental drug treatments. Click here to read the article by Rick Morgan of CNBC.

February 3, 2018 – Why A Cancer Patient Opposes The ‘Right To Try’ Experimental Cancer Drugs – Michael Becker is dying from cancer. But he tells NPR that he opposes the passage of the Right To Try Act, which gives terminally ill patients access to experimental drugs. Click here to listen to the interview by Scott Simon of NPR and/or read the transcript.

February 1, 2018 – I’m the ideal person to support right to try. But I can’t — it’s a disaster in the making Click here to read the opinion editorial by Michael Becker for STAT News.

2017

December 20, 2017What I Wish I’d Known Before Head and Neck Cancer Treatment: Michael offers 10 tips from his experience with oropharyngeal cancer treatment, from how to get support to nutrition and oral care. Click here to view the slideshow on HealthCentral.

December 16, 2017The Infection Connection: One-fifth of all cancers are caused by viral infections. New treatment and prevention strategies are in the works. Click here to read the article by Arlene Weintraub of CURE Magazine.

December 6, 2017Walking with purpose after an HPV-related head and neck cancer diagnosisClick here to read the article by the NCI’s Center for Cancer Research.

December 1, 2017Young Men Should Be Required to Get the HPV Vaccine. It Would Have Saved Me From CancerClick here to read the opinion editorial by Michael Becker for The Daily Beast.

November 26, 2017Making final words count: Author urges vaccinations against HPVClick here to read the article by Ajhani Ayres of Republican-American ($ access).

November 22, 2017An awkward conversation about HPV in men will save lives — just not mineClick here to read the opinion editorial by Michael Becker for NBC THINK.

November 22, 2017According to a study published last month on Annals of Internal Medicine, a medical journal, males in the U.S. are contracting the human papillomavirus (HPV) at a higher rate than femalesClick here to read the article by Brittney L Jackson of USA TODAY Network.

November 7, 2017Know what’s worse than the risks of getting the HPV vaccine? Getting an HPV-related cancer. Trust me.Click here to read the opinion editorial by Michael Becker for STAT News.

October 30, 2017The news earlier this month that 1 in 9 men — some 11.5 percent — are infected with the oral form of human papillomavirus (HPV) didn’t surprise Michael Becker — but it does alarm himClick here to read the article by Steve Dorfman of the Palm Beach Post.

September 13, 2017Michael D. Becker, cancer survivor and author of “A Walk With Purpose: Memoir of a Bioentrepreneur” discusses how he realized that he had head and neck cancer –  Click here to view the video interview on CURE TV.

September 7, 2017What if you build, but they don’t come; Why Michael Becker Says Industry Must Help Promote HPV-Related Cancer Prevention – Click here to read the opinion editorial by Michael Becker for BioCentury (many, many thanks to BioCentury for making this important article freely available to both non-subscribers and subscribers!)

August 10, 2017Bucks County author Michael Becker talks about his memoir ‘A Walk with Purpose’Click here to listen to a replay of the 20-minute interview by Dave Heller of NPR member radio station WHYY for the NewsWorks Tonight Segment.

July 22, 2017A former biotech executive who’s living with terminal cancer wants to reset expectations about new cancer treatments – Click here to read the article by Lydia Ramsey of Business Insider.

July 13, 2017A Shot Could Have Prevented the Cancer That’s Killing Me – Click here to read the article by Diana Spechler of Tonic, a website and digital video channel that covers wellness, science and big-picture health issues.

July 12, 2017Man With Stage IV Cancer Urges HPV Vaccination in New Memoir– Click here to read the article by Lara DeSanto of HealthCentral.

July 9, 2017A Patient’s Warning – Click here to read the article by Marie McCullough of The Philadelphia Inquirer.

July 7, 2017This Bucks biotech exec got terminal cancer. It shattered his preconceived ideas on care – Click here to read the article by John George, Senior Reporter at the Philadelphia Business Journal ($ access)

June 23, 2017Former Oncology Biotech CEO Battling Terminal Cancer Gives Unique Insight in New Gripping Memoir – Click here to read the article for Let Life Happen by Barbara Jacoby, an award-winning blogger.

June 19, 2017A Walk with Purpose: Michael Becker’s Memoir on Fearlessly Embracing Change – Click here to read the article by Anna Idler of Bucks Happening, the premier digital magazine of Bucks County, PA.

June 15, 2017Man Who Dedicated Career To Fighting Cancer Now Battling Terminal Disease – Click here to read the article and/or view a replay of the television segment where Michael Becker is interviewed by reporter Anita Oh for CBS 3’s Eyewitness News.

June 1, 2017BioWorld’s 11th annual Summer Reading List– “A Walk with Purpose: Memoir of a Bioentrepreneur” is among the four dozen books included in BioWorld’s popular summer reading list – Click here to read the article by Marie Powers of BioWorld.

May 23, 2017 BioNJ’s BioPartnering event– BioNJ President and CEO, Debbie Hart, had the pleasure of presenting former BioNJ Chairman, Michael Becker, with a special award during BioNJ BioPartnering Meeting, in honor of Michael’s life’s work within the biopharmaceutical community.

May 19, 2017Anti-Cancer Club – Interview with author Michael D. Becker of “A Walk with Purpose: Memoir of a Bioentrepreneur” – Click here to read the article by the Anti-Cancer Club.

2013

9/5/2013 – “Hopes For Glaxo’s MAGE-A3 Vaccine Grow Dim As Trial Misses Endpoint” by Emily Hayes of “The Pink Sheet”

8/14/2013 – “Immunotherapy Hits New Peak: ASCO Data Stir Excitement, Investment” by Anita T. Shaffer of OncLive

2012

6/27/2012 – “High Points and Hurdles: Immunotherapy Moves Forward” by Anita T. Shaffer of OncLive

5/7/2012 – “Insight: Training immune system to fight cancer comes of age” by Bill Berkrot of Reuters

3/2/2012 – “Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex’s Crash” by By Adam Feuerstein of TheStreet.com

2/27/2012 – “Dendreon Shares Drop on Slowing Sales of Cancer Vaccine Provenge” by Brett Chase of Minyanville

1/26/2012 – “Amgen, Celgene, Roche Deals Signal M&A Frenzy for Drug Companies” by Brett Chase of Minyanville

1/5/2012 – “Dendreon reports spike in Provenge sales; shares soar” by Bill Berkrot of Reuters

2011

10/11/2011 – “Nobel prize-winning science should incubate deals” by David Holley of The Deal

10/7/2011 – “Zytiga creeps up on Provenge prostate-cancer drug” by Ransdell Pierson of Reuters

8/23/2011 – “What’s a Cancer Drug Worth?” by Brett Chase of Minyanville

8/22/2011 – “With Dendreon Humbled, Lessons Learned For Cancer Vaccine Makers” by Emily Hayes of The Pink Sheet

8/17/2011 – “Daiichi Sankyo is poster company for sector ripe for M&A” by David Holley of The Deal Pipeline

8/4/2011 – “Dendreon plunges as Provenge prospects wither” by by Bill Berkrot of Reuters

8/4/2011 – “Dendreon’s Stock Plunges on Low Provenge Sales” by Brett Chase of Minyanville

6/30/2011 – “Medicare to cover Dendreon’s prostate drug” by Anna Yukhananov of Reuters

5/17/2011 – “Vical, Exelixis Surge as Cancer Meeting Nears” by Brett Chase of Minyanville

4/25/2011 – “Survivor, biotech” by David Holley of The Deal LLC; accompanying video interview replay available by clicking here

3/25/2011 – “Bristol-Myers’ Skin Cancer Drug Gets FDA Nod” by Brett Chase of Minyanville

3/11/2011 – “Copying Dendreon” by Brett Chase of Minyanville

2/27/2011 – “Analysis: Genzyme money seen flowing to other take-out targets” by Bill Berkrot of Reuters

2/7/2011 – “Betting Wrong on the FDA” by Brett Chase of Minyanville

2/4/2011 – “Analysis: The FDA casino and the high rollers of health funds” by Lisa Richwine and Daniel Bases of Reuters

2010

Nov 2010 – MD Becker Partners listed as featured growth company in Pennsylvania online business magazine Keystone Edge

Nov 2010 – “Pitfalls and Promise for Pancreatic Cancer” by Michael D. Becker for Oncology Business Review

11/5/2010 – “Pharma Ramps Up Research On Vaccines To Treat Cancer” By Peter Benesh of Investor’s Business Daily

10/21/10 – Welcoming remarks by Michael Becker at inaugural “Cancer Immunotherapy: A Long-Awaited Reality” conference in New York – see video clip below:

05/06/10 – “Dendreon Got Big Okay, But Still Faces Hurdles” by Peter Benesh of Investor’s Business Daily

04/30/10 – “Dendreon Drug Approval Raises Hopes for Others, Industry” by Thomas Gryta of Dow Jones Newswires

2008

11/10/08 – “Veteran Industry Executive Michael D. Becker Establishes Consultancy” press release

8/1/08 – “Discovering Cures in the Garden State” By Bari Adelman for NJ Savvy Living

6/30/08 – “NJ Biotechnology Industry Survey Sees Growth and Maturity” press release by BioNJ

3/10/08 – “Biotech Firms Await Healthier Investment Climate” By Shankar P. for NJBIZ

2007

10/29/07 – “For Biotech Investors, ASCO’s Now an Open Book ” By Adam Feuerstein for TheStreet.com

9/26/07 – “Biotechnology Council of New Jersey (BCNJ) Becomes BIONJ Reflecting Major Organizational Growth and Alignment with National Organization, BIO” press release

9/1/07 – “Ink and Inc.: How ASCO’s Media Policies Affect the Oncology Industry” By Jessica Wapner for Oncology Business Review

Sep 2007 – “Radiopharmaceuticals Need a Jump Start” by Michael Becker for Oncology Business Review

08/09/07 – “Cytogen’s Shift” By Jeff May of the Star Ledger

2006

12/18/06 – “The New Boss: Younger Than the Old Boss – U.S. CEOs 40 and Under” By Marc Hogan for Business Week

9/1/06 – Michael Becker and former New York City Mayor Rudy Giuliani ring The NASDAQ Stock Market Opening Bell to help kick off Prostate Cancer Awareness Month and the fifth annual “Screen, Stage and Support” campaign to promote prostate cancer education – video replay below:

2005

6/23/05 – Ernst & Young “Entrepreneur Of The Year” Awards Banquet in New Jersey

5/23/05 – Finalists for Ernst & Young “Entrepreneur Of The Year” Awards Announced in New Jersey

2004

9/9/04 – Michael Becker and New York Yankees legend Lou Piniella ring The NASDAQ Stock Market Opening Bell to help kick off Prostate Cancer Awareness Month and the fourth annual “Screen, Stage and Support” campaign to promote prostate cancer education

06/17/04 – Ernst & Young Entrepreneur of the Year 2004 Awards Gala – New Jersey. Finalist video replay below:

5/20/04 – Judges Select 31 Finalists For Ernst & Young “Entrepreneur of The Year” Awards Competition

2003

9/5/03 – Michael Becker and New York Yankees Hall of Famer Whitey Ford ring The NASDAQ Stock Market Opening Bell to help kick off Prostate Cancer Awareness Month and the third annual “Screen, Stage and Support” campaign to promote prostate cancer education – video replay below:

2002

12/17/02 – “Cytogen Corporation Announces Changes in Senior Management – Michael Becker Appointed CEO” via PR Newswire

2001

5/9/01 – “‘ASCO Effect’ Is Bad Medicine for Investors Not in the Know” By Adam Feuerstein for TheStreet.com

4/9/01 – “Michael D. Becker Appointed VP Investor Relations and Corporate Communications at Cytogen” via PR Newswire

3/27/01 – “Biotech Feels the Nasdaq’s Chill, and Its Multiples Are Shriveling” By Adam Feuerstein for TheStreet.com

3/26/01 – “ImClone Systems, biotech stocks add to gains” By Ted Griffith for CBS MarketWatch

3/21/01 – “Analysts Speculate on Fate of Biotech Stocks in Economic Downturn” By Naomi Aoki for The Boston Globe

3/16/01 – “Biotech in the Market for a Cure” By by Kristen Philipkoski for Wired News

3/16/01 – “Sector Watch: Biotech Stocks Socked, but Some See Upside” By Yi Ping Ho for TheStreet.com

3/14/01 – “Biotechs Up; Offering Defense, High Growth In Tough Mkt” Dow Jones Newswires story 5283 by Beth M. Mantz

03/14/01 – “Biotech shares gain in choppy market” By Reuters

3/12/01 – “Biotechnology shares tumble” By Ted Griffith for CBS MarketWatch

3/12/01 – “Cash woes afflict local medical firm” Crain’s Chicago Business story by Sarah A. Klein

3/11/01 – “The Replacements: Why The Vacanti Brothers Are The Fab Four Of Tissue Engineering” By Jeffrey Krasner for The Boston Globe

3/05/01 – “Biotechnology for Beginners” By Gayle Ronan for CNBC.com

3/05/01 – “Chip Off the Old Block?” By Forbes

2/14/01 – “Biology by computer” By Naomi Aoki for The Boston Globe

2/13/01 – “Alkermes Up 5% After Beating Street’s 3Q Estimate” Dow Jones Newswires story by Chinita L. Anderson

2/13/01 – “IGEN Intl Execs Face Lawsuit On Meso Scale Venture” Dow Jones Newswires story by Kathy Chu

2/12/01 – “Celera powers biotech gains” By Ted Griffith for CBS MarketWatch

2/05/01 – “Biotech company selling Alzheimer’s disease test, researching possible…” By Linda A. Johnson, Associated Press Business Writer

1/24/01 – “Striking at low tide Third Wave hopes IPO timing is right” By Jeff Richgels for The Capital Times

1/15/01 – “Company Maps Protein Interactions” By Linda A. Johnson, Associated Press Business Writer

1/11/01 – “Cytogen tops biotech stocks” By Ted Griffith for CBS MarketWatch

1/10/01 – “Cytogen’s protein-map success lifts its shares” By Ed Silverman for Star-Ledger

1/08/01 – “Fresh drag sucks ‘hot air’ out of sector” By Ted Griffith for CBS MarketWatch

1/08/01 – “Local firm’s genetic test gets a workout in study” Crain’s Chicago Business story by Sarah A. Klein

1/01/01 – “Abbott’s biotech biz gets a booster shot” Crain’s Chicago Business story by Sarah A. Klein

January/February 2001 – “Betting on Biotech: Can the momentum be sustained?” Bloomberg Personal Finance Online by Sophia Pearson

1/01/01 – “Six great investment ideas: Biotech – For investors, the revolution in genetics has only just begun” Mutual Funds magazine story by Greg Carlson

2000

12/25/00 – “Strategies for Stocks: Biotech Should Keep Rolling” Business Week article by Ellen Licking

12/12/00 – “Invest New Jersey: Stock To Watch Section” Business News New Jersey by Shankar P.

12/01/00 – “The Dawning of the Biotech Revolution” Business Finance magazine story by Shari Caudron

12/01/00 – “Biotech shares rebound” By Ted Griffith for CBS MarketWatch

11/13/00 – “Motorola is stepping up biochip biz” Crain’s Chicago Business story by Sarah A. Klein

11/08/00 – “Pharmaceutical stocks surge, biotechs give up early gains” By Ted Griffith for CBS MarketWatch

10/27/00 – “Biotech Sector Drops, Led By Bellwether Amgen, Analyst Calls Situation Overreaction” Dow Jones Newswires story 4339 by Beth M. Mantz

10/25/00 – Michael Becker, editor of Beck On Biotech newsletter, presented at the Chicago Biotech Network’s Second Annual BioMarketplace Investor Conference held at Motorola’s Museum Auditorium in Schaumburg.

10/25/00 – “Genomics Economics” article in Volume 21, Number 5 of the Journal of Business Strategy by Kent Steinriede

10/02/00 – “Biz world makes better petri dish” Crain’s Chicago Business story by Sarah A. Klein

09/28/00 – Michael Becker, editor of Beck On Biotech newsletter, presented at the Chicago Investor’s ’00 event hosted by The Chicago Stock Exchange, PC Quote.com, and Newsradio 780, WBBM. The event was held at the Palmer House Hilton, Chicago, IL.

09/26/00 – “Cell Pathways, biotech stocks slide” By Ted Griffith for CBS MarketWatch

09/18/00 – “Pharmaceutical company seeks right IPO chemistry” Crain’s Chicago Business story by Sarah A. Klein

09/01/00 – “Genome, Sweet Genome” SmartMoney magazine article by David Stires (quote appears on page 36)

09/01/00 – “Upbeat about economy, investors bid stocks higher” San Diego Union-Tribune article by Lisa Singhania

08/29/00 – “Princeton, N.J.-Based Biotech Firm Calls Off Acquisition; Enters Smaller Deal” by Bob Fernandez of the Philadelphia Inquirer

08/29/00 – “Cytogen kills merger after bad feedback” The Times (Trenton) by Tony Hagen

08/28/00 – “Another Biotech Boom Could Bloom Soon” Streetside with Dan Dorfman for JAGfn.com

08/28/00 – “Adv Magnetics Holders Sore As Cytogen Merger Ends” Dow Jones Newswires story 3645 by Beth M. Mantz

08/28/00 – “Xoma Up 26%; U.S. Bancorp Piper Ups 24-Mos Target To $18” Dow Jones Newswires story 3356 by Kathy Chu

08/28/00 – “Xoma rises on psoriasis drug, upgrade” Reuters English News Service

08/25/00 – “Biotech stocks push higher” By Ted Griffith for CBS MarketWatch

08/24/00 – “Biotech Stocks Up: Analysts Cite NIH Rules, Momentum Hldrs” Dow Jones Newswires story 5068 by Beth M. Mantz

08/21/00 – “Cytogen Up 19% After Bullish Knight Ridder Article” Dow Jones Newswires story 3811 by Kathy Chu

08/13/00 – “Biotech analysts bullish on sector” By Ted Griffith for CBS MarketWatch

08/10/00 – “Genomics Stks Dn: ‘Confluence of Events’ Leads To Dn Day” Dow Jones News Story 5761 by K. Maxwell Murphy

08/08/00 – “Biotech stocks cool off Tuesday” By Ted Griffith for CBS MarketWatch

08/08/00 – “For West Chester biotech firm, market has been far from sleepy” by Andrea Knox for the Philadelphia Inquirer

08/07/00 – Stock Market Observer (SMO) interview by Steve Ruxton on Channel 26 TV regarding the biotechnology sector. (WCIU-TV, Chicago, IL) – video replay below:

08/01/00 – “Investors dive back into biotech Tuesday” By Ted Griffith for CBS MarketWatch

07/24/00 – Dick Davis Digest, page 7, Vol. 19 No. 436

07/21/00 – “Biotech stocks lifted by profits, Amgen ruling” By Ted Griffith for CBS MarketWatch

07/12/00 – “Analyst Credits Narcolepsy Drug for Jolt in Cephalon Shares” in the Philadelphia Inquirer

07/11/00 – “Cytogen to Acquire Mass. Firm” in the Philadelphia Inquirer

07/11/00 – “Cytogen Ready to Expand” The Times (Trenton) by Andrew D. Smith

07/06/00 – “La Jolla Soars Almost 50%” By Amy Tsao for Smallcapcenter.com

07/06/00 – “La Jolla Pharma Up 22%;Approaching Phase III Trial Cited” Dow Jones News Story 4972 by Miatta V. David

06/28/00 – “Biotech Stocks Rally After Two Days Of Profit-Taking” Dow Jones News Story 5444 by Christine Nuzum

06/27/00 – Appearance on WTTW television show Chicago Tonight regarding the sequencing of the human genome

06/26/00 – Dick Davis Digest, page 7, Vol. 19 No. 434

06/26/00 – “Genomics tool makers move into spotlight” Reuters News Story by Deena Beasley

06/21/00 – “Proteomics, not Genomics, may lead to the New Era of Drug Discovery” According to Beck On Biotech press release

06/16/00 – Chicago Biotech Network press release welcoming new city and state resources for biotech and details regarding upcoming biotech business seminar

06/13/00 – Interview by Steve Ruxton on Channel 26 TV regarding the biotechnology sector. (WCIU-TV, Chicago, IL)

06/12/00 – “The Slow, Painful Path to Payday in Genomic Stocks” online edition of Business Week story by David Shook

06/06/00 – “Genomics Stks -3: Others Jump On Sector Movement” Dow Jones News story 4848 by Dinah Wisenberg Brin & Desiree J. Hanford

05/19/00 – Report by Carol Massar on Bloomberg TV regarding companies to watch at the upcoming American Society of Clinical Oncology (ASCO) meeting quoting Michael Becker – video replay below:

05/17/00 – “Cytogen Up from the Ashes – Again” The Times (Trenton) News Story by Andrew D. Smith

05/05/00 – “Organogenesis skin product faces new review”, Reuters News Story by Lisa Richwine

05/01/00 – “Biotech Movers: Magainin, Alkermes Lead Gains”, Bloomberg News Story by Brett Chase

04/28/00 – “Biotechs Up -3: Cancer Conference Starting Season-Analyst” Dow Jones News Story 4848 by Beth M. Mantz

04/24/00 – “Biotech startup rides fast track” Crain’s Chicago Business story by Meera Somasundaram

04/24/00 – “Biotechs: Catch a Risky Wave” Business Week article by Ellen Licking

04/14/00 – “Biotechs Dn -2: ‘Hanging In There, Relatively Speaking’ ” Dow Jones News Story 4046 by Beth M. Mantz

04/14/00 – “Letter to Dan: Cytogen Slides, but Bull Holds Firm”, Streetside with Dan Dorfman

04/08/00 – “How to Get a Biotech Education Without Going to Medical School” by TheStreet.com story by Mark Ingebretsen

04/05/00 – “Genomics Stks Up -2: Seems Clinton Took Back Words – Analyst” Dow Jones News Story 3774 by Beth M. Mantz

03/30/00 – “Myriad Genetics 2M Share-Offering Postponed – 3: Analyst Cites Competition” Dow Jones News Story 2886 by Beth M. Mantz

03/27/00 – “The Biotechnology Revolution” Beck On Biotech Newsletter press release

03/27/00 – Dick Davis Digest, page 5, Vol. 19 No. 428

03/24/00 – “Organogenesis Revisited” WorldlyInvestor.com by Robert Cyran

03/24/00 – “Genomics Stks Dn – 2: Investors Sorting Business Models” Dow Jones News Story 3921 by Beth M. Mantz

03/23/00 – “The Skinny on Organogenesis” WorldlyInvestor.com by Robert Cyran

03/21/00 – “Immunex Up – 3: Analyst Sees Key Reversal In Biotechs” Dow Jones News Story 5033 by Beth M. Mantz

03/21/00 – “Biotech Stks Slide – 4: Analyst Ties Myriad Move To Patent” Dow Jones News Story 5894 by Christine Nuzum

03/15/00 – “Biotechnology Industry Fundamentally Strong, Sector Decline Due to Confusion” According to the Beck On Biotech Newsletter press release

03/15/00 – “Cashing in on Biotech Bashing”, Streetside with Dan Dorfman

03/11/00 – “Advanced Tissue Sciences Soars on Positive Report on Skin Grafts”, Los Angeles Times Home Edition Page C-3

03/10/00 – “Genetic Data Luring Motorola – computer systems needed to analyze information”, story in Business Section of Chicago Tribune (Section 3/Page 3)

03/10/00 – “Advanced Tissue Up: Observer Notes Product Still Unapproved” Dow Jones News Story 3807 by Laura Elizabeth Pohl

03/10/00 – “Advanced Tissue Shares Rocket on Laboratory Study of Dermagraft”, Bloomberg News Story by Kristin Reed

03/09/00 – Michael Becker presented at the Chicago Biotech Network forum, “The Future of the Bioinformatics Industry in Illinois,” 8:00 A.M. to 12 Noon, at the University of Illinois at Chicago, in the Main Auditorium of the Molecular Biology Research Building, 900 South Ashland Avenue, Chicago.

03/08/00 – “Salt Lake City-Based Biotechnology Firm Looks To Raise $300 Million” The Salt Lake Tribune – Utah

03/08/00 – “Pro Predicts Biotechs Will Boom Again”, Streetside with Dan Dorfman

03/02/00 – “Chicago Biotech Network Hosts Bioinformatics Forum“, PR Newswire

02/22/00 – “Stocks To Watch: Booming Biotechs“, regarding Cytogen (CYTO) Business News New Jersey

02/17/00 – Cytogen Corp. (CYTO) Dow Jones News Story 4339 by Donna Fuscaldo

02/17/00 – Telephone interview by Bloomberg’s Jim Finkle regarding proteomics companies.  Available for replay via Bloomberg.

02/16/00 – “Growing a Product and Perhaps a Firm” Organogenesis (ORG) story in the business section (pages D1 & D6) of The Boston Globe

02/16/00 – Interview with Michael Becker by Carol Massar on Bloomberg TV regarding recent developments in the biotechnology industry and company recommendations – video replay below:

02/13/00 – “Chicago Biotech Network Celebrates First Birthday” press release

02/11/00 – Cytogen Corp. (CYTO) Dow Jones News Story 3244 by Riva Richmond

02/10/00 – Cytogen Corp. (CYTO) Dow Jones News Story 5521 by Elizabeth Souder

01/17/00 – Dick Davis Digest, page 8, Vol. 19 No. 423

01/11/00 – Interview by Linda Marshall on Channel 26 TV regarding the biotechnology sector. (WCIU-TV, Chicago, IL)

01/10/00 – “Biotech startups’ health is improving” Crain’s Chicago Business

01/06/00 – Cytogen Corp. (CYTO) Bloomberg News Story

01/06/00 – Cytogen Corp. (CYTO) Dow Jones News Story 4340

01/03/00 – Stock Market Observer (SMO) interview by Steve Ruxton on Channel 26 TV regarding the biotechnology sector. (WCIU-TV, Chicago, IL)

1999

12/27/99 – Dick Davis Digest, page 9, Vol. 18 No. 422

12/17/99 – “Organogenesis appoints new chairman, president/CEO”, page 45, Boston Herald

10/29/99 – Keynote speaker at Chicago Biotech Network’s “BioMarketplace ’99” – video replay below:

10/21/99 – Release by the Chicago Biotech Network for BioMarketplace ’99

09/27/99 – “Technology Today” section, page 28, Boston Herald

09/27/99 – “Invest New Jersey” section, Business News New Jersey

09/13/99 – Dick Davis Digest, page 7, Vol. 18 No. 415

09/06/99 – “Will Biotechnology’s Dreams Finally Come True?“, Business News New Jersey

08/24/99 – Chiron Corp. (CHIR) Dow Jones News Story 3322

08/23/99 – “Biotech Stocks’ Increases Drive DJ Biotech Index Up 3.5%” Dow Jones News Story 3934

08/09/99 – “Stock to Watch: Cytogen” Invest New Jersey section, Business News New Jersey

07/21/99 – “Biopharmaceutical Industry Exhibiting Strength, Consolidation Continues” according to the Beck On Biotech newsletter

07/07/99-07/08/99 – Panelist at the Bay Area Biomedical Investment Conference (BABIC) hosted by Russell Welsh

06/07/99 – “Invest New Jersey” section, Business News New Jersey

05/03/99 – “Invest New Jersey” section, Business News New Jersey

04/22/99 – Stock Market Observer (SMO) interview by Steve Ruxton on Channel 26 TV regarding the biotechnology sector. (WCIU-TV, Chicago, IL)

04/12/99 – “Change of Image” page 11, Business News New Jersey

03/03/99 – Presented at the Biotechnology Council of New Jersey, Inc. – “Breakfast with BCNJ”

02/23/99 – Alkermes Inc. (ALKS) Dow Jones News Story 4969

02/22/99 – NeoPharm Inc. (NEO) Dow Jones News Story 4009

01/18/99 – “A Man on a Rescue Mission” page 8, Business News New Jersey

1998

11/16/98 – “Biopharmaceutical Industry Rebounds in October,” According to the Beck On Biotech Newsletter

07/01/98 – “Once a Darling, Cytogen Now Tests Investors’ Patience” Dow Jones News Story 3353 by Jennifer Fron Mauer

1995

06/19/95 – “In Search of Investment Tools on Internet” in the Chicago Tribune by Bill Barnhart

June 1995 – “On and Off the Info Highway” Registered Representative magazine by Rosalyn Retkwa